✦ LIBER ✦

Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer

✍ Scribed by David E. Cohn; Sue Valmadre; Kimberly E. Resnick; Lynne A. Eaton; Larry J. Copeland; Jeffrey M. Fowler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab displays activity in refract

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Bevacizumab shows activity in advanced r

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Bevacizumab demonstrates activity in adv

✍ N. ARORA; D. TEWARI; C. COWAN; B. SAFFARI; B.J. MONK; R.A. BURGER 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Activity of bevacizumab (rhuMAB VEGF) in

✍ Bradley J. Monk; David C. Choi; Gordon Pugmire; Robert A. Burger 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Docetaxel/irinotecan combination chemoth

✍ Kimio Ushijima,Toshiharu Kamura… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 185 KB

Phase II prospective study of weekly top

✍ K.F. McGonigle; H.G. Muntz; J. Vuky; P.J. Paley; D.S. Veljovich; H.J. Gray; T.W. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB